Telsar Pharma, Inc. — Form D

Telsar Pharma, Inc. of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-18. The offering totals $14.0M, of which $14.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2012-05-18
Form: D
Accession: 0000897069-12-000271
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $14.0M
Amount sold: $14.0M
Investors: 26
Date of first sale: 2012-04-24
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-178492

Issuer

Name: Telsar Pharma, Inc.
CIK: 0001549817
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2012
Address: 520 US HIGHWAY 22, BRIDGEWATER, NJ, 08807
Phone: (908) 895-1200

Officers, directors & promoters (9)

Name	Role	Location
Jeffrey L Bird	Director	Palo Alto, CA
Robert L Desjardins	Director	Bridgewater, NJ
Arnold L Oronsky	Director	Baltimore, MD
Donna L Tempel	Director	Bridgewater, NJ
Christopher L Del Mastro	Executive Officer	Bridgewater, NJ
Robert L Desjardins	Executive Officer	Bridgewater, NJ
Donna L Tempel	Executive Officer	Bridgewater, NJ
Robert L Desjardins	Promoter	Bridgewater, NJ
Donna L Tempel	Promoter	Bridgewater, NJ

More